Black men are more than twice as likely as white men to develop prostate cancer and die from it, the Journal-Constitution reports. In addition, on average, prostate cancer develops five years earlier, and the tumors grow and spread more quickly in blacks than in whites.
Researchers attribute the disparity to biology, diet, environment and inadequate access to care. Only a small percentage of prostate cancer research funding goes toward finding the causes of disparities between black and white men, the Journal-Constitution reports.
Frequent Screening Doesn’t Help Prostate Cancer Patients Much
Frequent screening could of course help detect more tumours in the case of prostate cancer patients, failed to cut the number of aggressive tumors detected in between scheduled screenings.
Advertisement
Rep. Jim Marshall (D-Ga.) said, "There is no reason" that prostate cancer should not receive the same government funding and support provided for breast and cervical cancer among minority women. Marshall in May introduced legislation that would make prostate cancer screenings available to the poor, as breast and cervical cancer screenings are available at no-cost to poor women.
James Mohler, a leading clinical researcher, said about prostate cancer advocacy, "We're not in Washington, D.C., advocating. We're not out there screaming like we ought to be".
Source: Kaiser Family Foundation
JAY /J
Source: Kaiser Family Foundation
JAY /J
Prostate Cancer - Asians Have The Edge
New research says that prostate cancer can follow significantly different tracks in different ethnic groups.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
![Prostate Specific Antigen [PSA]](https://www.medindia.net/images/patientinfo/120x100/prostate-specific-antigen.jpg "Prostate Specific Antigen [PSA]")
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
